The Toronto Star interviewed Canadians with terminal illnesses who are having difficulty accessing magic mushrooms legally through the Health Canada Special Access Program, for which Filament is the primary supplier of psilocbyin.
Recent News
These patients are considering MAiD. They say Canada has made it harder to access magic mushrooms — a treatment giving them reason to live
The Toronto Star
November 13, 2024